Jonathan P. Uy

Real-World Effectiveness of 9–12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry

T. Fitzgerald, R. McLean, K. Callis Duffin, 2022, Dermatology and Therapy.

Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis Registry

T. Fitzgerald, R. McLean, K. Callis Duffin, 2022, Dermatology and Therapy.

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

Hillel P. Cohen, Donna Beydoun, D. Chien, 2016, Advances in Therapy.

Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR

B. Strober, A. Gottlieb, K. Papp, 2021, Drug Safety.

The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry

T. Fitzgerald, A. Armstrong, R. McLean, 2023, Advances in therapy.